drugset / Trial / NCT02255370

Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease

NCT02255370

RandomizedParallel-groupDouble-blindTreatment

Summary

Curcumin, the active ingredient of turmeric, has been used for long term in the treatment of inflammatory conditions. Inhibition of NF-κB is postulated as the main mechanism responsible for the anti-inflammatory effect of curcumin Aim : to study the effect of curcumin, 3g per day, as compared to placebo, combined with thiopurines in the prevention of Crohn's disease post-operative recurrence.

Timeline

Start
2014-12
Primary completion
2017-11
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 3 g Oral

Indications